Has Antifungal Susceptibility Testing Come of Age?

Has antifungal susceptibility testing come of age?

The in vitro susceptibility of an infecting organism to the antimicrobial agent selected for therapy is one of several factors that influence the likelihood that therapy for an infection will be successful. To appreciate the value of antifungal susceptibility testing, it is helpful to review the overall predictive utility of antibacterial susceptibility testing. After >30 years of study, in vit...

Multimedia Conferencing: Has It Come of Age? Multimedia Conferencing: Has It Come of Age?

Antifungal susceptibility testing.

Antifungal susceptibility testing has been in routine use now for more than 15 years and has become a useful tool for clinicians who are faced with difficult treatment decision. Although most clinicians order susceptibility testing, much confusion still exists regarding the use of the results. Sufficient data have been generated to determine susceptibility trends for specific fungi against spec...

Personalized antifungal susceptibility testing.

Introduction In recent years, the remarkable increase in the number of infections caused by fungal pathogens, especially in immunocompromised people, has stimulated interest in medical mycology in general and in antifungal susceptibility testing in particular. 1,2 In-vitro procedures for determining the activity of drugs against mould and yeast isolates involve clinicians in the choice and moni...

Has C-Peptide Come of Age?

n this issue, a Consensus Statement on proinsulin Cpeptide is published summarizing the deliberations of an international group of investigators, who met in Detroit in October 2000. This was preceded by the 3rd International Motor City Symposium, the theme of which was concerned with the clinical and biological effects of C-peptide. The abstracts of the presentations at the Symposium are also p...